4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: A report from the resolute all-comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent with an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)

Journal of the American College of Cardiology

Volumn 63, Issue 16, 2014, Pages 1617-1625

  Taniwaki, Masanori ^a   Stefanini, Giulio G ^a   Silber, Sigmund ^b   Richardt, Gert ^c   Vranckx, Pascal ^d   Serruys, Patrick W ^e   Buszman, Pawel E ^f   Kelbaek, Henning ^g   Windecker, Stephan ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b Kardiologische Praxis und Praxisklinik   (Germany)

^c Segeberger Kliniken GmbH   (Germany)

^d Department of Cardiology and Critical Care Medicine Hartcentrum Hasselt ^*  (Belgium)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g Rigshospitalet   (Denmark)

Author keywords

all comers population; drug eluting stent(s); everolimus eluting stent(s); long term outcomes; Resolute zotarolimus eluting stent(s)

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS;

ADULT; AGE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE FAILURE; DEVICE SAFETY; DIABETES MELLITUS; DRUG ELUTING CORONARY STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THERAPY EFFECT;

ALL-COMERS POPULATION; DRUG-ELUTING STENT(S); EVEROLIMUS-ELUTING STENT(S); LONG-TERM OUTCOMES; RESOLUTE ZOTAROLIMUS-ELUTING STENT(S);

ANTINEOPLASTIC AGENTS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSTHESIS DESIGN; REOPERATION; SIROLIMUS; TIME FACTORS;

EID: 84898950220     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.12.036     Document Type: Article

References (16)

1. G.G. Stefanini, and D.R. Holmes Jr. Drug-eluting coronary-artery stents N Engl J Med 368 2013 254 265
2. S. Silber, S. Windecker, P. Vranckx, and P.W. Serruys Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial Lancet 377 2011 1241 1247
3. K. Tandjung, H. Sen, and M.K. Lam et al. Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE Trial J Am Coll Cardiol 61 2013 2406 2416
4. P.W. Serruys, S. Silber, and S. Garg et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
5. P. Vranckx, D.E. Cutlip, and R. Mehran et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies EuroIntervention 5 2010 871 874
6. D.E. Cutlip, S. Windecker, and R. Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
7. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
8. L. Raber, M. Magro, and G.G. Stefanini et al. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study Circulation 125 2012 1110 1121
9. G.G. Stefanini, U. Baber, and S. Windecker et al. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials Lancet 382 2013 1879 1888
10. S. Bangalore, S. Kumar, and M. Fusaro et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
11. A. Kastrati, A. Schomig, and S. Elezi et al. Predictive factors of restenosis after coronary stent placement J Am Coll Cardiol 30 1997 1428 1436
12. P.A. Lemos, A. Hoye, and D. Goedhart et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study Circulation 109 2004 1366 1370
13. N. Mercado, E. Boersma, and W. Wijns et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era J Am Coll Cardiol 38 2001 645 652
14. A. Kastrati, A. Dibra, and J. Mehilli et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents Circulation 113 2006 2293 2300
15. T. Kimura, T. Morimoto, and Y. Nakagawa et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry Circulation 126 2012 1225 1236
16. G.W. Stone, A. Maehara, and A.J. Lansky et al. A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235